6 արդյունքներ
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a method for preventing and/or treating osteoporosis and other disease states in animal subjects, utilizing organic boron compounds.
2. Description of the Related Art
The adult skeleton is composed of 80% cortical
BACKGROUND OF THE INVENTION
Diseases affecting the connective tissues of the body have been the subject of a great deal of investigation for the past two decades. The essential amino acid L-hydroxyproline is an important constituent of proteins, particularly those proteins comprising the connective
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to new effectors of dipeptidyl peptidase IV (DP IV) and methods of treatment comprising the topical application thereof. These effectors can be used for targeted influencing of locally limited pathophysiological and
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to new effectors of dipeptidyl peptidase IV (DP IV) and methods of treatment comprising the topical application thereof. These effectors can be used for targeted influencing of locally limited pathophysiological and
This application is of PCT/IB 99/00626, filed Apr. 9, 1999.
This invention refers to the use of soluble Ketoprofen salts with amino acids for administration through the injectable, transdermal/mucosal and oral routes. These new compounds in addition to increasing the solubility of the active
BACKGROUND OF THE INVENTION
Diseases affecting the connective tissues of the body have been the subject of a great deal of investigation for the past two decades. The essential amino acid L-hydroxyproline is an important constituent of proteins, particularly those proteins comprising the connective